Gene therapy duo takes on tough lung cancer

NCT ID NCT05703971

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study tests a new gene therapy (quaratusugene ozeplasmid) combined with an immunotherapy drug (atezolizumab) as maintenance treatment for people with extensive-stage small cell lung cancer. The goal is to see if this combination can keep the cancer from growing longer than standard care. About 62 adults whose cancer responded to initial chemo-immunotherapy will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gabrail Cancer Center Research

    RECRUITING

    Canton, Ohio, 44718, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Portland, Oregon, 97213-2982, United States

    Contact

    Contact Email: •••••@•••••

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Portland, Oregon, 97227, United States

    Contact

    Contact Email: •••••@•••••

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Tigard, Oregon, 97223, United States

    Contact

    Contact Email: •••••@•••••

  • Northwest Cancer Specialists, P.C.

    TERMINATED

    Vancouver, Washington, 98684, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45211, United States

    Contact

    Contact Email: •••••@•••••

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45236, United States

    Contact

    Contact Email: •••••@•••••

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45242, United States

    Contact

    Contact Email: •••••@•••••

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45245, United States

    Contact

    Contact Email: •••••@•••••

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Fairfield, Ohio, 45014, United States

    Contact

    Contact Email: •••••@•••••

  • Providence Cancer Institute

    RECRUITING

    Portland, Oregon, 97213, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Rocky Mountain Cancer Centers, LLP

    RECRUITING

    Lone Tree, Colorado, 80124, United States

    Contact Email: •••••@•••••

    Contact

  • Texas Oncology - DFW

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Email: •••••@•••••

    Contact

  • Texas Oncology - Northeast Texas

    RECRUITING

    Tyler, Texas, 75702, United States

    Contact

    Contact Email: •••••@•••••

  • Virginia Cancer Specialists, PC

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

    Contact Email: •••••@•••••

  • Washington University School of Medicine - Siteman Cancer Center

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Willamette Valley Cancer Institute (Oregon)

    RECRUITING

    Eugene, Oregon, 97401, United States

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.